| Not Yet Recruiting | HSK3486 (Cipepofol) Injectable Emulsion for Induction of General Anesthesia in Pediatric Subjects Undergoing E General Anesthetic | Phase 3 | 2026-05-01 |
| Not Yet Recruiting | A Clinical Trial Evaluating the Efficacy and Safety of HSK55718 in Patients for Postoperative Pain Treatment i Pain After Surgery | Phase 2 | 2026-04-20 |
| Not Yet Recruiting | Evaluating the Efficacy and Safety of of HSK44459 in People With Progressive Pulmonary Fibrosis Progressive Pulmonary Fibrosis | Phase 3 | 2026-04-05 |
| Not Yet Recruiting | A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase III Study to Evaluate the Efficacy and Safet IPF | Phase 3 | 2026-04-05 |
| Recruiting | A Phase I Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and the Food Effect of HSK55879 Tablet Healhty | Phase 1 | 2026-03-20 |
| Not Yet Recruiting | Long-Term Safety and Efficacy of HSK39004 Dry Powder Inhaler in COPD Chronic Obstructive Lung Disease (COLD) | Phase 2 | 2026-03-01 |
| Recruiting | A Study for HSK47388 in Participants With Ulcerative Colitis Ulcerative Colitis (UC) | Phase 2 | 2026-02-03 |
| Recruiting | Phase Ⅲ Study of Efficacy and Safety of HSK39297 Tablet in Treatment of Patients With Primary IgAN IgA Nephropathy (IgAN) | Phase 3 | 2026-02-01 |
| Recruiting | Study to Assess Efficacy and Safety of HSK39297 Tablets in Patients With LN Lupus Nephritis (LN) | Phase 2 | 2025-11-18 |
| Not Yet Recruiting | A Multicenter, Randomized, Open-Label, Parallel-Controlled Clinical Study Comparing the Efficacy and Safety of Type 2 Diabetes | N/A | 2025-10-01 |
| Not Yet Recruiting | A Phase II Efficacy and Safety Study of HSK44459 in Subjects With Moderate to Severe Plaque Psoriasis Psoriasis | Phase 2 | 2025-09-26 |
| Not Yet Recruiting | A Phase 2 Study of HSK47388 Tablets to Evaluate the Efficacy and Safety in Patients With Moderate-to-Severe Pl Plaque Psoriasis | Phase 2 | 2025-09-01 |
| Recruiting | A Study to Assess PK, Safety and Efficacy of HSK47977 Tablets in Subjects With Relapsed or Refractory Non-Hodg NHL | Phase 1 | 2025-08-28 |
| Recruiting | Phase I Study of HSK42360 in Malignant Brain Tumors With BRAF V600 Mutation Malignant Brain Tumors | Phase 1 | 2025-08-15 |
| Active Not Recruiting | Evaluation of the Safety and Efficacy of HSK39004 Dry Powder Inhaler in Chinese Patients With Chronic Obstruct Chronic Obstructive Pulmonary Disease (COPD) | Phase 2 | 2025-08-13 |
| Enrolling By Invitation | Clinical Study to Evaluate the Effect of Itraconazole on the Pharmacokinetics of HSK31858 in Healthy Subjects Healthy Subjects | Phase 1 | 2025-08-11 |
| Completed | Food Effect Study of HSK47388 in Healthy Subjects Pharmaceutical Preparations, Health Adult Subjects | Phase 1 | 2025-08-08 |
| Recruiting | A Clinical Trial Evaluating the Efficacy and Safety of HSK21542 in Patients for Postoperative Pain Treatment i Postoperative Pain Management | Phase 3 | 2025-07-28 |
| Active Not Recruiting | A Clinical Study Evaluating the Pharmacokinetics and Pharmacodynamics of HSK39004 Inhalation Suspension in COP COPD Patients | Phase 2 | 2025-07-28 |
| Not Yet Recruiting | A Long-term Study of HSK44459 Tablets in Participants With Bechet's Disease Bechet's Disease | Phase 2 | 2025-07-01 |
| Not Yet Recruiting | Long-term Safety and Efficacy Study of HSK44459 Tablets in Patients With Idiopathic Pulmonary Fibrosis (IPF) Idiopathic Pulmonary Fibrosis (IPF) | Phase 2 | 2025-06-27 |
| Recruiting | Investigation of Pharmacokinetics,Safety,and Pharmacodynamics of HSK39297 in Subjects With Hepatic Impairment Paroxysmal Nocturnal Hemoglobinuria (PNH) | Phase 1 | 2025-05-29 |
| Completed | Efficacy and Safety of HSK39297 in Anti-C5 Treated PNH Patients With Anemia Paroxysmal Nocturnal Haemoglobinuria (PNH) | Phase 3 | 2025-05-12 |
| Not Yet Recruiting | This Study is to Evaluate the Safety, Tolerability, and Pharmacokinetics (PK) of HSK47388 in Healthy Volunteer Healthy | Phase 1 | 2025-05-01 |
| Active Not Recruiting | Evaluation of the Safety and Efficacy of HSK39004 Dry Powder Inhaler and HSK39004 Inhalation Suspension in Chi Chronic Obstructive Lung Disease (COLD) | Phase 2 | 2025-04-24 |
| Recruiting | Phase I Study of HSK41959 in Solid Tumors With MTAP Deletion Advanced Solid Tumors | Phase 1 | 2025-04-11 |
| Not Yet Recruiting | Evaluating the Efficacy and Safety of of HSK44459 in Patients With Behçet's Disease Behcet's Disease | Phase 2 | 2025-03-24 |
| Completed | A Phase III Study to Evaluate the Efficacy and Safety of HSK39297 in Patients With Paroxysmal Nocturnal Hemogl PNH | Phase 3 | 2025-02-13 |
| Completed | Phase I Clinical Trial to Evaluate the Safety, Tolerability and Pharmacokinetic Characteristics of HSK39004 Dr Healthy Volunteers | Phase 1 | 2025-02-10 |
| Completed | Evaluating the Efficacy and Safety of of HSK44459 in People With Idiopathic Pulmonary Fibrosis Idiopathic Pulmonary Fibrosis | Phase 2 | 2025-01-17 |
| Recruiting | A Study to Evaluate the Accuracy of aTCI Model of Cipepofol in Patients With General Anesthesia During Electiv Anesthesia | Phase 4 | 2025-01-06 |
| Recruiting | Long-term Safety and Tolerability of HSK39297 in Patients With Paroxysmal Nocturnal Hemoglobinuria Paroxysmal Nocturnal Hemoglobinuria | Phase 2 | 2025-01-03 |
| Recruiting | Phase I Study of HSK46575 in Patients With Metastatic Castration-Resistant Prostate Cancer m CRPC | Phase 1 | 2024-12-18 |
| Enrolling By Invitation | A Study to Evaluate the Efficacy and Safety of HSK31858 Tablets in Patients with Airway Mucus Hypersecretion Asthma Bronchiale, Bronchiectasis, Chronic Obstructive Pulmonary Disease (COPD) | Phase 2 | 2024-12-10 |
| Active Not Recruiting | Clinical Study to Evaluate the Effect of Rifampicin on the Pharmacokinetics of HSK31858 in Healthy Subjects Healthy Subjects | Phase 1 | 2024-10-28 |
| Enrolling By Invitation | A Study to Evaluate the Efficacy and Safety of HSK31858 Tablets in Patients with Bronchial Asthma Bronchial Asthma | Phase 2 | 2024-10-22 |
| Recruiting | Phase II Study of Efficacy and Safety of HSK39297 Tablet in Treatment of Patients with Primary IgAN IgA Nephropathy (IgAN) | Phase 2 | 2024-10-12 |
| Recruiting | A Study to Assess the Efficacy and Safety of HSK31858 in Participants With Non-Cystic Fibrosis Bronchiectasis Non-cystic Fibrosis Bronchiectasis | Phase 3 | 2024-09-30 |
| Completed | A Phase 2 Clinical Trial Evaluating the Efficacy and Safety of HSK21542 in Patients for Postoperative Pain Tre Postoperative Pain Management | Phase 2 | 2024-09-13 |
| Completed | Study on Mass Balance of [14C]HSK39297 in Healthy Chinese Adult Male Subjects Paroxysmal Nocturnal Hemoglobinuria (PNH) | Phase 1 | 2024-09-09 |
| Completed | Phase I Clinical Trial to Evaluate the Safety, Tolerability, Pharmacokinetic Characteristics, and Primary Effi Healthy Donors | Phase 1 | 2024-09-02 |
| Completed | A Phase I Study to Assess the Safety,Tolerability, PK, PD, and Food Effect of HSK44459 in Healthy Subjects Healthy | Phase 1 | 2024-08-17 |
| Completed | A Study to Evaluate the Efficacy and Safety of HSK39297 in Patients With Paroxysmal Nocturnal Hemoglobinuria（P Paroxysmal Nocturnal Hemoglobinuria (PNH) | Phase 2 | 2024-07-17 |
| Recruiting | Phase I Study of HSK42360 in Solid Tumors With BRAF V600 Mutation Solid Tumors | Phase 1 | 2024-06-25 |
| Not Yet Recruiting | Efficacy and Safety of HSK16149 Capsule in the Treatment of Moderate and Severe Central Neuropathic Pain in Ch Central Neuropathic Pain | Phase 3 | 2024-05-30 |
| Recruiting | Efficacy and Safety of HSK16149 Capsule in Chinese Patients With Diabetic Peripheral Neuropathic Pain Who Had Diabetic Peripheral Neuropathic Pain | Phase 2 | 2024-04-19 |
| Completed | A Multicenter, Open, Controlled, Phase III Clinical Study to Evaluate the Efficacy and Safety of Cipepofol Inj Anesthesia | Phase 3 | 2024-04-07 |
| Completed | A Study on Switching From Daily DPP-4 Inhibitor to HSK7653 in Type 2 Diabetes Patients Type 2 Diabetes | Phase 2 | 2024-01-15 |
| Completed | To Evaluate the Efficacy and Safety of HSK31679 in Chinese Patients With Non-Alcoholic Steatohepatitis (NASH) Non-Alcoholic Steatohepatitis (NASH) | Phase 2 | 2024-01-05 |
| Completed | A Phase I Study to Assess the Safety,Tolerability, PK, PD, and Food Effect of HSK39297 in Healthy Subjects Healthy | Phase 1 | 2023-12-25 |
| Completed | A Study to Evaluate the Safety and Efficacy of HL231 Solution for Inhalation in Patients With COPD Chronic Obstructive Pulmonary Disease (COPD) | Phase 3 | 2023-12-11 |
| Completed | Metabolism and Excretory of HSK21542 in Maintenance Hemodialysis Patients Chronic Kidney Disease Patients | Phase 1 | 2023-10-10 |
| Unknown | To Evaluate the Efficacy and Safety of HSK16149 With L-carnitine in Diabetic Peripheral Neuralgia Patients in Diabetic Peripheral Neuropathic Pain | N/A | 2023-05-01 |
| Completed | Study of HSK31679 in Subjects With Hypercholesterolemia With Nonalcoholic Fatty Liver Disease（NAFLD） Hypercholesterolemia | Phase 2 | 2023-04-26 |
| Unknown | A Study to Evaluate the Pharmacokinetics of HSK21542 in Subjects With Renal Impairment Renal Impairment | Phase 1 | 2023-04-24 |
| Recruiting | Phase I Study of HSK40118 in NSCLC Patients With EGFR Mutation NSCLC | Phase 1 | 2023-03-27 |
| Completed | The Drug-drug Interaction of HSK16149 Capsule With Probenecid Tablets or Cimetidine Tablets in Healthy Subject PHN - Post-Herpetic Neuritis | Phase 1 | 2023-03-20 |
| Completed | HSK16149 for Perioperative Analgesia in Orthopedic Surgery Post-operative Pain | Phase 2 | 2023-03-08 |
| Completed | To Evaluate the Efficacy and Safety of HSK16149 Capsule in Chinese Patients With Herpetic Neuralgia Herpetic Neuralgia | Phase 2 | 2023-02-27 |
| Completed | A Study to Evaluate the Pharmacokinetics of HSK16149 in Subjects With Renal Impairment Renal Impairment | Phase 1 | 2022-12-12 |
| Completed | A Study of HSK31858 in Participants with Non-Cystic Fibrosis Bronchiectasis Non-cystic Fibrosis Bronchiectasis (NCFBE) | Phase 2 | 2022-12-06 |
| Unknown | A Clinical Study to Evaluate the Efficacy, Safety and PK/PD Profiles of Anticoagulation of HSK36273 for Inject Renal Replacement Therapy | Phase 2 | 2022-11-01 |
| Completed | A Study to Evaluate the Pharmacokinetics of HSK7653 in Subjects With Renal Impairment Renal Impairment | Phase 1 | 2022-08-04 |
| Completed | A Clinical Trial Evaluating the Efficacy and Safety of HSK21542 in Patients with Chronic Kidney Disease-Associ Pruritus, Hemodialysis Patients with Moderate-to-Severe Pruritus | Phase 3 | 2022-06-17 |
| Completed | Relative Bioavailability and Pharmacodynamics of HSK7653 in Healthy Volunteers Healthy | Phase 1 | 2022-06-15 |
| Completed | A Clinical Trial Evaluating the Efficacy and Safety of HSK21542 in Patients for Postoperative Pain Treatment Postoperative Analgesia | Phase 3 | 2022-06-08 |
| Completed | A Study of Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple Ascending Dosed of HSK36273 Healthy | Phase 1 | 2022-04-11 |
| Completed | Safety, Tolerability,PK/PD, Food Effect of Single and Multiple Ascending Doses of HSK31858 in Healthy Voluntee Healthy Volunteers | Phase 1 | 2022-02-23 |
| Completed | Ascending Single-Dose and Multiple-Dose Study to Evaluate HSK31679 in Healthy Subjects and Subjects With Eleva Healthy, Elevated LDL-C | Phase 1 | 2022-02-22 |
| Completed | To Evaluate the Long-term Safety and Efficacy of HSK16149 in Chinese Patients With Peripheral Neuralgia Peripheral Neuropathic Pain | Phase 3 | 2022-02-17 |
| Completed | A Trial to Evaluate the Safety and Efficacy of HL231 Solution for Inhalation in Patients with COPD Chronic Obstructive Pulmonary Disease (COPD) | Phase 2 | 2022-01-12 |
| Completed | Drug-drug Interaction Between Ciprofol and Mefanamic Acid or Valproate Drug Drug Interaction | Phase 1 | 2021-12-17 |
| Completed | To Evaluate the Efficacy and Safety of HSK16149 Capsule in Chinese Patients With Postherpetic Neuralgia Postherpetic Neuralgia | Phase 3 | 2021-11-01 |
| Completed | A Study of Safety, Tolerability, and Pharmacokinetics of Single Ascending Dosed of HSK31858 in Healthy Volunte Healthy | Phase 1 | 2021-10-28 |
| Completed | A Clinical Trial Evaluating the Efficacy, Safety, and Pharmacokinetics of HSK21542 Injection in Liver Disease Pruritus | Phase 2 | 2021-09-16 |
| Unknown | Efficacy and Safety of Ciprofol Compared to Propofol for Nonintubated General Anesthesia in Patients Undergoin Anesthesia, General | Phase 4 | 2021-09-03 |
| Unknown | A Study of HSK29116 in Adults With Relapsed/Refractory B-cell Malignancies Relapsed/Refractory B-Cell Malignancies | Phase 1 | 2021-08-24 |
| Completed | Phase III Clinical Trial Evaluating the Efficacy and Safety of Ciprofol Injection for the Induction of Sedatio Gynecological Outpatient Surgery | Phase 3 | 2021-07-26 |
| Completed | Pharmacokinetics, Mass Balance, and Metabolism of [14C]HSK21542 in Healthy Adult Male Volunteers. Peripheral Analgesic and Anti-itch | Phase 1 | 2021-06-15 |
| Unknown | A Study Evaluating Drug-Drug Interaction (DDI) Between HSK16149 Capsules and Metformin Hydrochloride Tablets Diabetic Neuropathies, Diabetic Neuropathy Peripheral | Phase 1 | 2021-04-01 |
| Completed | HSK7653 in Chinese Patients with Impaired Glucose Tolerance Impaired Glucose Tolerance | Phase 2 | 2021-03-29 |
| Completed | A Clinical Study to Evaluate Efficacy and Safety of HSK21542 for Postoperative Analgesia of Subjects Undergoin Postoperative Analgesia | Phase 3 | 2021-03-24 |
| Completed | A Clinical Study Evaluating Sedation of Intravenous Administration of HSK3486 in ICU Patients Undergoing Long- Sedation in Intensive Care | Phase 2 | 2021-03-09 |
| Completed | Safety, Tolerability and Pharmacokinetics of FTP-198 Tablet in Healthy Chinese Volunteers Healthy | Phase 1 | 2020-12-23 |
| Completed | A Study Evaluating Sedation of Intravenous Administration of HSK3486 Injectable Emulsion in ICU Patients Under Sedation in Intensive Care | Phase 3 | 2020-12-08 |
| Unknown | To Evaluate the Efficacy and Safety of HSK16149 Capsule in Chinese Patients With Diabetic Peripheral Neuropath Diabetic Peripheral Neuropathic Pain | Phase 2 / Phase 3 | 2020-12-02 |
| Completed | A Study to Evaluate the Efficacy and Safety of HSK3486 in the Induction of General Anesthesia Induction and Maintenance of General Anesthesia | Phase 3 | 2020-11-24 |
| Completed | Bioequivalence Study of Ranolazine Extended-release Tablets in Healthy Chinese Subjects Healthy | Phase 1 | 2020-09-06 |
| Completed | A Study Evaluating the Efficacy and Safety of HSK21542 Injection for Analgesia in Subjects Undergoing Colonosc Analgesia | Phase 2 | 2020-08-19 |
| Completed | A Study Evaluating the Safety, Pharmacokinetics, and Efficacy of HSK21542 Injection in Subjects Undergoing Hem Uremic Pruritus | Phase 2 | 2020-08-10 |
| Completed | Study of Acetyllevocarnitine Hydrochloride Tablets in Chinese Patients With Paresthesias Caused by DPN Diabetic Peripheral Neuropathy (DPN), Paresthesia | Phase 3 | 2020-07-23 |
| Completed | Efficacy and Safety of HSK21542 in Inducing Postoperative Analgesia in Undergoing Elective Laparoscopic Surger Analgesia | Phase 2 | 2020-07-02 |
| Completed | A Study to Evaluate the Differences in Pharmadynamics, Pharmacokinetics, and Safety Between Ciprofol and Propo Anesthesia | Phase 1 | 2020-05-26 |
| Completed | A Study to Evaluate the DDI of HSK7653 With Metformin Type 2 Diabetes Mellitus | Phase 1 | 2019-08-10 |
| Completed | Multiple-dose Study to Evaluate the Safety,Tolerability, Pharmacokinetics and Pharmacodynamics of HSK7653 in T Type 2 Diabetes Mellitus | Phase 2 | 2019-01-22 |
| Completed | Bioequivalence Study of Propofol Medium and Long Chain Fat Emulsion Injection in Healthy Chinese Subjects Healthy | Phase 1 | 2018-10-16 |
| Completed | Single Escalating Dose Study Of HSK7653 In Healthy Subjects T2DM (Type 2 Diabetes Mellitus) | Phase 1 | 2018-05-08 |
| Completed | Bioequivalence Study of Pramipexole Dihydrochloride Extended-release Tablets in Healthy Chinese Subjects Healthy | Phase 1 | 2017-03-16 |